Literature DB >> 30567979

Comparative Analysis of Gammaherpesvirus Circular RNA Repertoires: Conserved and Unique Viral Circular RNAs.

Nathan A Ungerleider1, Vaibhav Jain2, Yiping Wang3, Nicholas J Maness4, Robert V Blair5, Xavier Alvarez5, Cecily Midkiff5, Dennis Kolson5, Shanshan Bai6, Claire Roberts1, Walter N Moss7, Xia Wang1, Jacqueline Serfecz3, Michael Seddon8, Terri Lehman8, Tianfang Ma9, Yan Dong9, Rolf Renne2, Scott A Tibbetts10, Erik K Flemington11.   

Abstract

Recent studies have identified circular RNAs (circRNAs) expressed from the Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV) human DNA tumor viruses. To gain initial insights into the potential relevance of EBV circRNAs in virus biology and disease, we assessed the circRNAome of the interspecies homologue rhesus macaque lymphocryptovirus (rLCV) in a naturally occurring lymphoma from a simian immunodeficiency virus (SIV)-infected rhesus macaque. This analysis revealed rLCV orthologues of the latency-associated EBV circular RNAs circRPMS1_E4_E3a and circEBNA_U. Also identified in two samples displaying unusually high lytic gene expression was a novel rLCV circRNA that contains both conserved and rLCV-specific RPMS1 exons and whose backsplice junctions flank an rLCV lytic origin of replication (OriLyt). Analysis of a lytic infection model for the murid herpesvirus 68 (MHV68) rhadinovirus identified a cluster of circRNAs near an MHV68 lytic origin of replication, with the most abundant of these, circM11_ORF69, spanning the OriLyt. Lastly, analysis of KSHV latency and reactivation models revealed the latency associated circRNA originating from the vIRF4 gene as the predominant viral circRNA. Together, the results of this study broaden our appreciation for circRNA repertoires in the Lymphocryptovirus and Rhadinovirus genera of gammaherpesviruses and provide evolutionary support for viral circRNA functions in latency and viral replication.IMPORTANCE Infection with oncogenic gammaherpesviruses leads to long-term viral persistence through a dynamic interplay between the virus and the host immune system. Critical for remodeling of the host cell environment after the immune responses are viral noncoding RNAs that modulate host signaling pathways without attracting adaptive immune recognition. Despite the importance of noncoding RNAs in persistent infection, the circRNA class of noncoding RNAs has only recently been identified in gammaherpesviruses. Accordingly, their roles in virus infection and associated oncogenesis are unknown. Here we report evolutionary conservation of EBV-encoded circRNAs determined by assessing the circRNAome in rLCV-infected lymphomas from an SIV-infected rhesus macaque, and we report latent and lytic circRNAs from KSHV and MHV68. These experiments demonstrate utilization of the circular RNA class of RNAs across 4 members of the gammaherpesvirus subfamily, and they identify orthologues and potential homoplastic circRNAs, implying conserved circRNA functions in virus biology and associated malignancies.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  EBV; Epstein-Barr virus; KSHV; Kaposi’s sarcoma herpesvirus; MHV68; circRNA; circular RNA; lymphocryptovirus; murid herpesvirus 68; rhadinovirus

Mesh:

Substances:

Year:  2019        PMID: 30567979      PMCID: PMC6401440          DOI: 10.1128/JVI.01952-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.

Authors:  Faryal Mehwish Awan; Burton B Yang; Anam Naz; Aneeqa Hanif; Aqsa Ikram; Ayesha Obaid; Arif Malik; Hussnain Ahmed Janjua; Amjad Ali; Sumaira Sharif
Journal:  RNA Biol       Date:  2020-07-13       Impact factor: 4.652

2.  Circular RNAs Represent a Novel Class of Human Cytomegalovirus Transcripts.

Authors:  Shaomin Yang; Xiaolian Liu; Mei Wang; Di Cao; Dabbu Kumar Jaijyan; Nicole Enescu; Jian Liu; Songbin Wu; Sashuang Wang; Wuping Sun; Lizu Xiao; Alison Gu; Yaolan Li; Hong Zhou; Sanjay Tyagi; Jianguo Wu; Qiyi Tang; Hua Zhu
Journal:  Microbiol Spectr       Date:  2022-05-23

Review 3.  Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses.

Authors:  Takanobu Tagawa; Anna Serquiña; Insun Kook; Joseph Ziegelbauer
Journal:  Semin Cell Dev Biol       Date:  2020-07-03       Impact factor: 7.727

Review 4.  Identifying and characterizing virus-encoded circular RNAs.

Authors:  Takanobu Tagawa; Vishal N Kopardé; Joseph M Ziegelbauer
Journal:  Methods       Date:  2021-03-11       Impact factor: 3.608

Review 5.  The many ways Epstein-Barr virus takes advantage of the RNA tool kit.

Authors:  Nara Lee
Journal:  RNA Biol       Date:  2021-01-30       Impact factor: 4.652

Review 6.  Gammaherpesvirus RNAs Come Full Circle.

Authors:  Nathan A Ungerleider; Scott A Tibbetts; Rolf Renne; Erik K Flemington
Journal:  mBio       Date:  2019-04-02       Impact factor: 7.867

7.  Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge.

Authors:  Tianpeng He; Xin Li; Dongmei Xie; Lili Tian
Journal:  Mol Med Rep       Date:  2019-08-26       Impact factor: 2.952

8.  High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.

Authors:  Hani Nakhoul; Zhen Lin; Xia Wang; Claire Roberts; Yan Dong; Erik Flemington
Journal:  mSphere       Date:  2019-07-10       Impact factor: 4.389

9.  Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs.

Authors:  Takanobu Tagawa; Daniel Oh; Jerico Santos; Sarah Dremel; Guruswamy Mahesh; Thomas S Uldrick; Robert Yarchoan; Vishal N Kopardé; Joseph M Ziegelbauer
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

10.  Alterations in cellular expression in EBV infected epithelial cell lines and tumors.

Authors:  Rachel Hood Edwards; Robert Dekroon; Nancy Raab-Traub
Journal:  PLoS Pathog       Date:  2019-10-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.